Cargando…

Treatment Challenges in Pediatric Stroke Patients

Aim. In this study we presented our experience of 18 years on the etiology, risk factors, prophylactic and acute treatment, the effect of treatment to recurrence rate of patients with stroke. Methods. The population included 108 patients who had been treated for stroke at Pediatric Neurology Departm...

Descripción completa

Detalles Bibliográficos
Autores principales: Yılmaz, A., Teber, S., Bektaş, Ö, Akar, N., Uysal, L. Z., Aksoy, E., Deda, G.
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018633/
https://www.ncbi.nlm.nih.gov/pubmed/21234312
http://dx.doi.org/10.4061/2011/534362
_version_ 1782196105564389376
author Yılmaz, A.
Teber, S.
Bektaş, Ö
Akar, N.
Uysal, L. Z.
Aksoy, E.
Deda, G.
author_facet Yılmaz, A.
Teber, S.
Bektaş, Ö
Akar, N.
Uysal, L. Z.
Aksoy, E.
Deda, G.
author_sort Yılmaz, A.
collection PubMed
description Aim. In this study we presented our experience of 18 years on the etiology, risk factors, prophylactic and acute treatment, the effect of treatment to recurrence rate of patients with stroke. Methods. The population included 108 patients who had been treated for stroke at Pediatric Neurology Department of Ankara University with the diagnosis of arterial ischemic stroke and sinovenous thrombosis between January 1992 and August 2010. Forty-one girls (38%) and 67 boys (62%) with mean symptom age 3.1 ± 4.04 years, (0–18 years old) were followed up with a mean period of 4.9 ± 3.78 years (0–17 years). Results. 30 patients had no risk factors, 34 patients had only one risk factor and 44 patients had multiple risk factors. Recurrence was seen in three patients. There was no any statistical correlation between the recurrence of stroke and the existence of risk factors (P = .961). Seventeen patients received prophylactic treatment; 2 of them without any risk factors, 3 had one risk factor, 12 patients, who constituted the majority of our patients, had multiple risk factors (P = .024). Conclusion. With this study we showed that the right prophylaxis for right patients reduces the rate of recurrence.
format Text
id pubmed-3018633
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-30186332011-01-13 Treatment Challenges in Pediatric Stroke Patients Yılmaz, A. Teber, S. Bektaş, Ö Akar, N. Uysal, L. Z. Aksoy, E. Deda, G. Stroke Res Treat Clinical Study Aim. In this study we presented our experience of 18 years on the etiology, risk factors, prophylactic and acute treatment, the effect of treatment to recurrence rate of patients with stroke. Methods. The population included 108 patients who had been treated for stroke at Pediatric Neurology Department of Ankara University with the diagnosis of arterial ischemic stroke and sinovenous thrombosis between January 1992 and August 2010. Forty-one girls (38%) and 67 boys (62%) with mean symptom age 3.1 ± 4.04 years, (0–18 years old) were followed up with a mean period of 4.9 ± 3.78 years (0–17 years). Results. 30 patients had no risk factors, 34 patients had only one risk factor and 44 patients had multiple risk factors. Recurrence was seen in three patients. There was no any statistical correlation between the recurrence of stroke and the existence of risk factors (P = .961). Seventeen patients received prophylactic treatment; 2 of them without any risk factors, 3 had one risk factor, 12 patients, who constituted the majority of our patients, had multiple risk factors (P = .024). Conclusion. With this study we showed that the right prophylaxis for right patients reduces the rate of recurrence. SAGE-Hindawi Access to Research 2010-12-28 /pmc/articles/PMC3018633/ /pubmed/21234312 http://dx.doi.org/10.4061/2011/534362 Text en Copyright © 2011 A. Yılmaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Yılmaz, A.
Teber, S.
Bektaş, Ö
Akar, N.
Uysal, L. Z.
Aksoy, E.
Deda, G.
Treatment Challenges in Pediatric Stroke Patients
title Treatment Challenges in Pediatric Stroke Patients
title_full Treatment Challenges in Pediatric Stroke Patients
title_fullStr Treatment Challenges in Pediatric Stroke Patients
title_full_unstemmed Treatment Challenges in Pediatric Stroke Patients
title_short Treatment Challenges in Pediatric Stroke Patients
title_sort treatment challenges in pediatric stroke patients
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018633/
https://www.ncbi.nlm.nih.gov/pubmed/21234312
http://dx.doi.org/10.4061/2011/534362
work_keys_str_mv AT yılmaza treatmentchallengesinpediatricstrokepatients
AT tebers treatmentchallengesinpediatricstrokepatients
AT bektaso treatmentchallengesinpediatricstrokepatients
AT akarn treatmentchallengesinpediatricstrokepatients
AT uysallz treatmentchallengesinpediatricstrokepatients
AT aksoye treatmentchallengesinpediatricstrokepatients
AT dedag treatmentchallengesinpediatricstrokepatients